High Risk Breast Cancer Screening Program

Breast Cancer Clinical Trial

Official title:

High Risk Breast Cancer Screening Program

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT00509509
• Other study ID #: OOTR-SBR001
• Status: Recruiting
• Phase: N/A
• First received: July 29, 2007
• Last updated: May 22, 2012

Study information

• Verified date: May 2012
• Source: Organisation for Oncology and Translational Research
• Contact: Louis WC Chow
• Phone: (852)2861 0286
• Email: lwcchow[@]unimed.hk
• Is FDA regulated: No
• Health authority: Hong Kong: Ethics Committee
• Study type: Observational

Clinical Trial Summary

Objectives:

• To screen population with high risk for breast cancer

• To promote the concept and importance of surveillance mammography

• To find out the incidence of breast cancer in population who are in high risk for breast cancer

• To collect blood samples for molecular analysis

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 0
• Gender: Female
• Age group: 41 Years and older

Eligibility

Inclusion Criteria:

• Female

• > 40 years of age

• Women who have first-degree relative suffered from breast cancer

• Women who have first-degree relative suffered from ovarian cancer

• Family history of male breast cancer

• Family history of breast cancer (not necessarily first degree relatives) diagnosed before age of 40

• Family history of breast cancer (not necessarily first degree relatives) affecting 2 or more family members

• Personal history of ovarian cancer

• Personal history of premalignant conditions of breast and ovary

Exclusion Criteria:

• Women with mammogram within one year

Study Design

Time Perspective: Prospective

Related Conditions & MeSH terms

• Breast Cancer
• Breast Neoplasms

Locations

Country	Name	City	State
Hong Kong	UNIMED Medical Institute	Wanchai

Sponsors (1)

Lead Sponsor	Collaborator
Organisation for Oncology and Translational Research

Country where clinical trial is conducted

Hong Kong,